Homo sapiens (human): 5894
Help
Entry
5894 CDS
T01001
Symbol
RAF1, CMD1NN, CRAF, NS5, Raf-1, c-Raf
Name
(RefSeq) Raf-1 proto-oncogene, serine/threonine kinase
KO
K04366
RAF proto-oncogene serine/threonine-protein kinase [EC:
2.7.11.1
]
Organism
hsa
Homo sapiens (human)
Pathway
hsa01521
EGFR tyrosine kinase inhibitor resistance
hsa01522
Endocrine resistance
hsa04010
MAPK signaling pathway
hsa04012
ErbB signaling pathway
hsa04014
Ras signaling pathway
hsa04015
Rap1 signaling pathway
hsa04022
cGMP-PKG signaling pathway
hsa04024
cAMP signaling pathway
hsa04062
Chemokine signaling pathway
hsa04068
FoxO signaling pathway
hsa04071
Sphingolipid signaling pathway
hsa04072
Phospholipase D signaling pathway
hsa04140
Autophagy - animal
hsa04150
mTOR signaling pathway
hsa04151
PI3K-Akt signaling pathway
hsa04210
Apoptosis
hsa04218
Cellular senescence
hsa04270
Vascular smooth muscle contraction
hsa04360
Axon guidance
hsa04370
VEGF signaling pathway
hsa04371
Apelin signaling pathway
hsa04510
Focal adhesion
hsa04540
Gap junction
hsa04550
Signaling pathways regulating pluripotency of stem cells
hsa04613
Neutrophil extracellular trap formation
hsa04625
C-type lectin receptor signaling pathway
hsa04630
JAK-STAT signaling pathway
hsa04650
Natural killer cell mediated cytotoxicity
hsa04660
T cell receptor signaling pathway
hsa04662
B cell receptor signaling pathway
hsa04664
Fc epsilon RI signaling pathway
hsa04666
Fc gamma R-mediated phagocytosis
hsa04720
Long-term potentiation
hsa04722
Neurotrophin signaling pathway
hsa04726
Serotonergic synapse
hsa04730
Long-term depression
hsa04810
Regulation of actin cytoskeleton
hsa04910
Insulin signaling pathway
hsa04912
GnRH signaling pathway
hsa04914
Progesterone-mediated oocyte maturation
hsa04915
Estrogen signaling pathway
hsa04916
Melanogenesis
hsa04917
Prolactin signaling pathway
hsa04919
Thyroid hormone signaling pathway
hsa04921
Oxytocin signaling pathway
hsa04926
Relaxin signaling pathway
hsa04928
Parathyroid hormone synthesis, secretion and action
hsa04929
GnRH secretion
hsa04935
Growth hormone synthesis, secretion and action
hsa05010
Alzheimer disease
hsa05022
Pathways of neurodegeneration - multiple diseases
hsa05034
Alcoholism
hsa05132
Salmonella infection
hsa05152
Tuberculosis
hsa05160
Hepatitis C
hsa05161
Hepatitis B
hsa05163
Human cytomegalovirus infection
hsa05164
Influenza A
hsa05165
Human papillomavirus infection
hsa05167
Kaposi sarcoma-associated herpesvirus infection
hsa05170
Human immunodeficiency virus 1 infection
hsa05200
Pathways in cancer
hsa05205
Proteoglycans in cancer
hsa05206
MicroRNAs in cancer
hsa05207
Chemical carcinogenesis - receptor activation
hsa05208
Chemical carcinogenesis - reactive oxygen species
hsa05210
Colorectal cancer
hsa05211
Renal cell carcinoma
hsa05212
Pancreatic cancer
hsa05213
Endometrial cancer
hsa05214
Glioma
hsa05215
Prostate cancer
hsa05218
Melanoma
hsa05219
Bladder cancer
hsa05220
Chronic myeloid leukemia
hsa05221
Acute myeloid leukemia
hsa05223
Non-small cell lung cancer
hsa05224
Breast cancer
hsa05225
Hepatocellular carcinoma
hsa05226
Gastric cancer
hsa05230
Central carbon metabolism in cancer
hsa05231
Choline metabolism in cancer
hsa05235
PD-L1 expression and PD-1 checkpoint pathway in cancer
Network
nt06110
MAPK signaling (viruses and bacteria)
nt06124
Chemokine signaling (viruses)
nt06150
Cytokine-cytokine receptor interaction (viruses)
nt06162
Hepatitis B virus (HBV)
nt06163
Hepatitis C virus (HCV)
nt06164
Kaposi sarcoma-associated herpesvirus (KSHV)
nt06166
Human papillomavirus (HPV)
nt06167
Human cytomegalovirus (HCMV)
nt06170
Influenza A virus (IAV)
nt06210
ERK signaling
nt06220
Calcium signaling
nt06224
CXCR signaling
nt06230
Cell cycle
nt06260
Colorectal cancer
nt06261
Gastric cancer
nt06262
Pancreatic cancer
nt06263
Hepatocellular carcinoma
nt06264
Renal cell carcinoma
nt06265
Bladder cancer
nt06266
Non-small cell lung cancer
nt06268
Melanoma
nt06270
Breast cancer
nt06271
Endometrial cancer
nt06273
Glioma
nt06274
Thyroid cancer
nt06275
Acute myeloid leukemia
nt06276
Chronic myeloid leukemia
nt06323
KISS1-GnRH-LH/FSH-E2 signaling
nt06324
GHRH-GH-IGF signaling
nt06361
Hypogonadotropic hypogonadism
nt06417
AGE-RAGE signaling
nt06460
Alzheimer disease
Element
N00001
EGF-EGFR-RAS-ERK signaling pathway
N00002
BCR-ABL fusion kinase to RAS-ERK signaling pathway
N00003
Mutation-activated KIT to RAS-ERK signaling pathway
N00004
Duplication or mutation-activated FLT3 to RAS-ERK signaling pathway
N00005
Mutation-activated MET to RAS-ERK signaling pathway
N00006
Amplified EGFR to RAS-ERK signaling pathway
N00007
EML4-ALK fusion kinase to RAS-ERK signaling pathway
N00008
RET fusion kinase to RAS-ERK signaling pathway
N00009
TRK fusion kinase to RAS-ERK signaling pathway
N00011
Mutation-activated FGFR3 to RAS-ERK signaling pathway
N00012
Mutation-activated KRAS/NRAS to ERK signaling pathway
N00014
Mutation-activated EGFR to RAS-ERK signaling pathway
N00015
PDGF-PDGFR-RAS-ERK signaling pathway
N00016
PDGF-overexpression to RAS-ERK signaling pathway
N00018
Amplified PDGFR to RAS-ERK signaling pathway
N00019
FGF-FGFR-RAS-ERK signaling pathway
N00020
Amplified FGFR to RAS-ERK signaling pathway
N00021
EGF-ERBB2-RAS-ERK signaling pathway
N00022
ERBB2-overexpression to RAS-ERK signaling pathway
N00023
EGF-EGFR-PLCG-ERK signaling pathway
N00024
Mutation-activated EGFR to PLCG-ERK signaling pathway
N00025
EML4-ALK fusion kinase to PLCG-ERK signaling pathway
N00041
EGFR-overexpression to RAS-ERK signaling pathway
N00077
HRAS-overexpression to ERK signaling pathway
N00078
Mutation-activated HRAS to ERK signaling pathway
N00152
CXCR-GNB/G-ERK signaling pathway
N00157
KSHV vGPCR to GNB/G-ERK signaling pathway
N00160
KSHV K1 to RAS-ERK signaling pathway
N00215
KITLG-KIT-RAS-ERK signaling pathway
N00216
HGF-MET-RAS-ERK signaling pathway
N00217
FLT3LG-FLT3-RAS-ERK signaling pathway
N00229
TGFA-EGFR-RAS-ERK signaling pathway
N00230
TGFA-overexpression to RAS-ERK signaling pathway
N00233
IGF-IGF1R-RAS-ERK signaling pathway
N00235
IGF2-overexpression to RAS-ERK signaling pathway
N00237
IGF1R-overexpression to RAS-ERK signaling pathway
N00246
HGF-overexpression to RAS-ERK signaling pathway
N00248
MET-overexpression to RAS-ERK signaling pathway
N00252
Amplified ERBB2 to RAS-ERK signaling pathway
N00259
Amplified MET to RAS-ERK signaling pathway
N00276
EGF-overexpression to RAS-ERK signaling pathway
N00277
EREG-EGFR-RAS-ERK signaling pathway
N00278
EREG-overexpression to RAS-ERK signaling pathway
N00279
AREG-EGFR-RAS-ERK signaling pathway
N00280
AREG-overexpression to RAS-ERK signaling pathway
N00367
HPV E5 to EGFR-RAS-ERK signaling pathway
N00369
HPV E5 to PDGFR-RAS-ERK signaling pathway
N00386
HCMV gB to PDGFR-RAS-ERK signaling pathway
N00392
HCMV gB to EGFR-RAS-ERK signaling pathway
N00513
Mutation-activated EGFR to RAS-ERK signaling pathway
N00518
HCV Core to ERK signaling pathway
N00538
Ca2+-PYK2-RAS-ERK signaling pathway
N00539
HBV HBx to Ca2+-PYK2-RAS-ERK signaling pathway
N00540
HBV HBx to RAS-ERK signaling pathway
N00541
HBV HBx to RAS-ERK signaling pathway
N00546
CXCL12-CXCR4-PKC-ERK signaling pathaway
N00547
HBV LHBs to PKC-ERK signaling pathway
N00744
IAV HA to ERK signaling pathway
N00873
GnRH-GnRHR-PLCB-PKC signaling pathway
N00875
Mutation-inactivated GnRHR to GnRH-GnRHR-PLCB-PKC signaling pathway
N00876
Mutation-inactivated FGF8 to RAS-ERK signaling pathway
N00877
Mutation-inactivated FGF17 to RAS-ERK signaling pathway
N00878
Mutation-inactivated FGFR1 to RAS-ERK signaling pathway
N00913
Mutation-inactivated IGF1 to RAS-ERK signaling pathway
N00914
Mutation-inactivated IGF1R to RAS-ERK signaling pathway
N00994
AGE-RAGE signaling pathway
N00996
Mutation-caused aberrant Abeta to AGE-RAGE signaling pathway
N01062
Mutation-activated MET to RAS-ERK signaling pathway
N01064
Mutation-activated RET to RAS-ERK signaling pathway
N01119
RAC/CDC42-PAK-ERK signaling pathway
N01336
CHRNA7-E2F signaling pathway
N01337
NNK/NNN to CHRNA7-E2F signaling pathway
N01343
ACH-CHRN-RAS-ERK signaling pathway
N01344
NNK/NNN to RAS-ERK signaling pathway
N01351
E2-ER-RAS-ERK signaling pathway
N01352
BPA to RAS-ERK signaling pathway
N01353
E2 to RAS-ERK signaling pathway
N01354
BPA to RAS-ERK signaling pathway
N01360
P4-PR-RAS-ERK signaling pathway
N01361
P4/MPA to PR-RAS-ERK signaling pathway
N01408
Metals to RAS-ERK signaling pathway
Disease
H00294
Dilated cardiomyopathy
H01984
Leopard syndrome
Drug target
Regorafenib (
DG00720
):
D10137
<JP/US>
D10138
Sorafenib (
DG00713
):
D06272
<JP/US>
D08524
Tovorafenib:
D12291
Brite
KEGG Orthology (KO) [BR:
hsa00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
5894 (RAF1)
04012 ErbB signaling pathway
5894 (RAF1)
04014 Ras signaling pathway
5894 (RAF1)
04015 Rap1 signaling pathway
5894 (RAF1)
04370 VEGF signaling pathway
5894 (RAF1)
04371 Apelin signaling pathway
5894 (RAF1)
04630 JAK-STAT signaling pathway
5894 (RAF1)
04068 FoxO signaling pathway
5894 (RAF1)
04072 Phospholipase D signaling pathway
5894 (RAF1)
04071 Sphingolipid signaling pathway
5894 (RAF1)
04024 cAMP signaling pathway
5894 (RAF1)
04022 cGMP-PKG signaling pathway
5894 (RAF1)
04151 PI3K-Akt signaling pathway
5894 (RAF1)
04150 mTOR signaling pathway
5894 (RAF1)
09140 Cellular Processes
09141 Transport and catabolism
04140 Autophagy - animal
5894 (RAF1)
09143 Cell growth and death
04210 Apoptosis
5894 (RAF1)
04218 Cellular senescence
5894 (RAF1)
09144 Cellular community - eukaryotes
04510 Focal adhesion
5894 (RAF1)
04540 Gap junction
5894 (RAF1)
04550 Signaling pathways regulating pluripotency of stem cells
5894 (RAF1)
09142 Cell motility
04810 Regulation of actin cytoskeleton
5894 (RAF1)
09150 Organismal Systems
09151 Immune system
04613 Neutrophil extracellular trap formation
5894 (RAF1)
04625 C-type lectin receptor signaling pathway
5894 (RAF1)
04650 Natural killer cell mediated cytotoxicity
5894 (RAF1)
04660 T cell receptor signaling pathway
5894 (RAF1)
04662 B cell receptor signaling pathway
5894 (RAF1)
04664 Fc epsilon RI signaling pathway
5894 (RAF1)
04666 Fc gamma R-mediated phagocytosis
5894 (RAF1)
04062 Chemokine signaling pathway
5894 (RAF1)
09152 Endocrine system
04910 Insulin signaling pathway
5894 (RAF1)
04929 GnRH secretion
5894 (RAF1)
04912 GnRH signaling pathway
5894 (RAF1)
04915 Estrogen signaling pathway
5894 (RAF1)
04914 Progesterone-mediated oocyte maturation
5894 (RAF1)
04917 Prolactin signaling pathway
5894 (RAF1)
04921 Oxytocin signaling pathway
5894 (RAF1)
04926 Relaxin signaling pathway
5894 (RAF1)
04935 Growth hormone synthesis, secretion and action
5894 (RAF1)
04919 Thyroid hormone signaling pathway
5894 (RAF1)
04928 Parathyroid hormone synthesis, secretion and action
5894 (RAF1)
04916 Melanogenesis
5894 (RAF1)
09153 Circulatory system
04270 Vascular smooth muscle contraction
5894 (RAF1)
09156 Nervous system
04726 Serotonergic synapse
5894 (RAF1)
04720 Long-term potentiation
5894 (RAF1)
04730 Long-term depression
5894 (RAF1)
04722 Neurotrophin signaling pathway
5894 (RAF1)
09158 Development and regeneration
04360 Axon guidance
5894 (RAF1)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
5894 (RAF1)
05206 MicroRNAs in cancer
5894 (RAF1)
05205 Proteoglycans in cancer
5894 (RAF1)
05207 Chemical carcinogenesis - receptor activation
5894 (RAF1)
05208 Chemical carcinogenesis - reactive oxygen species
5894 (RAF1)
05230 Central carbon metabolism in cancer
5894 (RAF1)
05231 Choline metabolism in cancer
5894 (RAF1)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
5894 (RAF1)
09162 Cancer: specific types
05210 Colorectal cancer
5894 (RAF1)
05212 Pancreatic cancer
5894 (RAF1)
05225 Hepatocellular carcinoma
5894 (RAF1)
05226 Gastric cancer
5894 (RAF1)
05214 Glioma
5894 (RAF1)
05221 Acute myeloid leukemia
5894 (RAF1)
05220 Chronic myeloid leukemia
5894 (RAF1)
05218 Melanoma
5894 (RAF1)
05211 Renal cell carcinoma
5894 (RAF1)
05219 Bladder cancer
5894 (RAF1)
05215 Prostate cancer
5894 (RAF1)
05213 Endometrial cancer
5894 (RAF1)
05224 Breast cancer
5894 (RAF1)
05223 Non-small cell lung cancer
5894 (RAF1)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
5894 (RAF1)
05161 Hepatitis B
5894 (RAF1)
05160 Hepatitis C
5894 (RAF1)
05164 Influenza A
5894 (RAF1)
05163 Human cytomegalovirus infection
5894 (RAF1)
05167 Kaposi sarcoma-associated herpesvirus infection
5894 (RAF1)
05165 Human papillomavirus infection
5894 (RAF1)
09171 Infectious disease: bacterial
05132 Salmonella infection
5894 (RAF1)
05152 Tuberculosis
5894 (RAF1)
09164 Neurodegenerative disease
05010 Alzheimer disease
5894 (RAF1)
05022 Pathways of neurodegeneration - multiple diseases
5894 (RAF1)
09165 Substance dependence
05034 Alcoholism
5894 (RAF1)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
5894 (RAF1)
01522 Endocrine resistance
5894 (RAF1)
09180 Brite Hierarchies
09181 Protein families: metabolism
01001 Protein kinases [BR:
hsa01001
]
5894 (RAF1)
Enzymes [BR:
hsa01000
]
2. Transferases
2.7 Transferring phosphorus-containing groups
2.7.11 Protein-serine/threonine kinases
2.7.11.1 non-specific serine/threonine protein kinase
5894 (RAF1)
Protein kinases [BR:
hsa01001
]
Serine/threonine kinases: TKL group
RAF family [OT]
5894 (RAF1)
BRITE hierarchy
SSDB
Ortholog
Paralog
Gene cluster
GFIT
Motif
Pfam:
PK_Tyr_Ser-Thr
Pkinase
RBD
C1_1
Kinase-like
ABC1
zf-RING-like
Pkinase_fungal
C1_2
Motif
Other DBs
NCBI-GeneID:
5894
NCBI-ProteinID:
NP_002871
OMIM:
164760
HGNC:
9829
Ensembl:
ENSG00000132155
Pharos:
P04049
(Tclin)
UniProt:
P04049
L7RRS6
Structure
PDB
LinkDB
All DBs
Position
3:complement(12583601..12664117)
Genome browser
AA seq
648 aa
AA seq
DB search
MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRV
FLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAAS
LIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKV
PTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTF
NTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNL
SPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSF
GTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIV
TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGL
TVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYE
LMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFP
QILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF
NT seq
1947 nt
NT seq
+upstream
nt +downstream
nt
atggagcacatacagggagcttggaagacgatcagcaatggttttggattcaaagatgcc
gtgtttgatggctccagctgcatctctcctacaatagttcagcagtttggctatcagcgc
cgggcatcagatgatggcaaactcacagatccttctaagacaagcaacactatccgtgtt
ttcttgccgaacaagcaaagaacagtggtcaatgtgcgaaatggaatgagcttgcatgac
tgccttatgaaagcactcaaggtgaggggcctgcaaccagagtgctgtgcagtgttcaga
cttctccacgaacacaaaggtaaaaaagcacgcttagattggaatactgatgctgcgtct
ttgattggagaagaacttcaagtagatttcctggatcatgttcccctcacaacacacaac
tttgctcggaagacgttcctgaagcttgccttctgtgacatctgtcagaaattcctgctc
aatggatttcgatgtcagacttgtggctacaaatttcatgagcactgtagcaccaaagta
cctactatgtgtgtggactggagtaacatcagacaactcttattgtttccaaattccact
attggtgatagtggagtcccagcactaccttctttgactatgcgtcgtatgcgagagtct
gtttccaggatgcctgttagttctcagcacagatattctacacctcacgccttcaccttt
aacacctccagtccctcatctgaaggttccctctcccagaggcagaggtcgacatccaca
cctaatgtccacatggtcagcaccaccctgcctgtggacagcaggatgattgaggatgca
attcgaagtcacagcgaatcagcctcaccttcagccctgtccagtagccccaacaatctg
agcccaacaggctggtcacagccgaaaacccccgtgccagcacaaagagagcgggcacca
gtatctgggacccaggagaaaaacaaaattaggcctcgtggacagagagattcaagctat
tattgggaaatagaagccagtgaagtgatgctgtccactcggattgggtcaggctctttt
ggaactgtttataagggtaaatggcacggagatgttgcagtaaagatcctaaaggttgtc
gacccaaccccagagcaattccaggccttcaggaatgaggtggctgttctgcgcaaaaca
cggcatgtgaacattctgcttttcatggggtacatgacaaaggacaacctggcaattgtg
acccagtggtgcgagggcagcagcctctacaaacacctgcatgtccaggagaccaagttt
cagatgttccagctaattgacattgcccggcagacggctcagggaatggactatttgcat
gcaaagaacatcatccatagagacatgaaatccaacaatatatttctccatgaaggctta
acagtgaaaattggagattttggtttggcaacagtaaagtcacgctggagtggttctcag
caggttgaacaacctactggctctgtcctctggatggccccagaggtgatccgaatgcag
gataacaacccattcagtttccagtcggatgtctactcctatggcatcgtattgtatgaa
ctgatgacgggggagcttccttattctcacatcaacaaccgagatcagatcatcttcatg
gtgggccgaggatatgcctccccagatcttagtaagctatataagaactgccccaaagca
atgaagaggctggtagctgactgtgtgaagaaagtaaaggaagagaggcctctttttccc
cagatcctgtcttccattgagctgctccaacactctctaccgaagatcaaccggagcgct
tccgagccatccttgcatcgggcagcccacactgaggatatcaatgcttgcacgctgacc
acgtccccgaggctgcctgtcttctag
Homo sapiens (human): 673
Help
Entry
673 CDS
T01001
Symbol
BRAF, B-RAF1, B-raf, BRAF-1, BRAF1, NS7, RAFB1
Name
(RefSeq) B-Raf proto-oncogene, serine/threonine kinase
KO
K04365
B-Raf proto-oncogene serine/threonine-protein kinase [EC:
2.7.11.1
]
Organism
hsa
Homo sapiens (human)
Pathway
hsa01521
EGFR tyrosine kinase inhibitor resistance
hsa01522
Endocrine resistance
hsa04010
MAPK signaling pathway
hsa04012
ErbB signaling pathway
hsa04015
Rap1 signaling pathway
hsa04024
cAMP signaling pathway
hsa04062
Chemokine signaling pathway
hsa04068
FoxO signaling pathway
hsa04150
mTOR signaling pathway
hsa04270
Vascular smooth muscle contraction
hsa04510
Focal adhesion
hsa04650
Natural killer cell mediated cytotoxicity
hsa04720
Long-term potentiation
hsa04722
Neurotrophin signaling pathway
hsa04726
Serotonergic synapse
hsa04730
Long-term depression
hsa04810
Regulation of actin cytoskeleton
hsa04910
Insulin signaling pathway
hsa04914
Progesterone-mediated oocyte maturation
hsa04928
Parathyroid hormone synthesis, secretion and action
hsa04934
Cushing syndrome
hsa05010
Alzheimer disease
hsa05022
Pathways of neurodegeneration - multiple diseases
hsa05034
Alcoholism
hsa05160
Hepatitis C
hsa05161
Hepatitis B
hsa05200
Pathways in cancer
hsa05205
Proteoglycans in cancer
hsa05208
Chemical carcinogenesis - reactive oxygen species
hsa05210
Colorectal cancer
hsa05211
Renal cell carcinoma
hsa05212
Pancreatic cancer
hsa05213
Endometrial cancer
hsa05214
Glioma
hsa05215
Prostate cancer
hsa05216
Thyroid cancer
hsa05218
Melanoma
hsa05219
Bladder cancer
hsa05220
Chronic myeloid leukemia
hsa05221
Acute myeloid leukemia
hsa05223
Non-small cell lung cancer
hsa05224
Breast cancer
hsa05225
Hepatocellular carcinoma
hsa05226
Gastric cancer
Network
nt06110
MAPK signaling (viruses and bacteria)
nt06124
Chemokine signaling (viruses)
nt06162
Hepatitis B virus (HBV)
nt06163
Hepatitis C virus (HCV)
nt06164
Kaposi sarcoma-associated herpesvirus (KSHV)
nt06166
Human papillomavirus (HPV)
nt06167
Human cytomegalovirus (HCMV)
nt06170
Influenza A virus (IAV)
nt06210
ERK signaling
nt06220
Calcium signaling
nt06260
Colorectal cancer
nt06261
Gastric cancer
nt06262
Pancreatic cancer
nt06263
Hepatocellular carcinoma
nt06264
Renal cell carcinoma
nt06265
Bladder cancer
nt06266
Non-small cell lung cancer
nt06268
Melanoma
nt06270
Breast cancer
nt06271
Endometrial cancer
nt06273
Glioma
nt06274
Thyroid cancer
nt06275
Acute myeloid leukemia
nt06276
Chronic myeloid leukemia
nt06324
GHRH-GH-IGF signaling
nt06361
Hypogonadotropic hypogonadism
nt06417
AGE-RAGE signaling
nt06460
Alzheimer disease
Element
N00001
EGF-EGFR-RAS-ERK signaling pathway
N00002
BCR-ABL fusion kinase to RAS-ERK signaling pathway
N00003
Mutation-activated KIT to RAS-ERK signaling pathway
N00004
Duplication or mutation-activated FLT3 to RAS-ERK signaling pathway
N00005
Mutation-activated MET to RAS-ERK signaling pathway
N00006
Amplified EGFR to RAS-ERK signaling pathway
N00007
EML4-ALK fusion kinase to RAS-ERK signaling pathway
N00008
RET fusion kinase to RAS-ERK signaling pathway
N00009
TRK fusion kinase to RAS-ERK signaling pathway
N00011
Mutation-activated FGFR3 to RAS-ERK signaling pathway
N00012
Mutation-activated KRAS/NRAS to ERK signaling pathway
N00013
Mutation-activated BRAF to ERK signaling pathway
N00014
Mutation-activated EGFR to RAS-ERK signaling pathway
N00015
PDGF-PDGFR-RAS-ERK signaling pathway
N00016
PDGF-overexpression to RAS-ERK signaling pathway
N00018
Amplified PDGFR to RAS-ERK signaling pathway
N00019
FGF-FGFR-RAS-ERK signaling pathway
N00020
Amplified FGFR to RAS-ERK signaling pathway
N00021
EGF-ERBB2-RAS-ERK signaling pathway
N00022
ERBB2-overexpression to RAS-ERK signaling pathway
N00023
EGF-EGFR-PLCG-ERK signaling pathway
N00024
Mutation-activated EGFR to PLCG-ERK signaling pathway
N00025
EML4-ALK fusion kinase to PLCG-ERK signaling pathway
N00041
EGFR-overexpression to RAS-ERK signaling pathway
N00077
HRAS-overexpression to ERK signaling pathway
N00078
Mutation-activated HRAS to ERK signaling pathway
N00160
KSHV K1 to RAS-ERK signaling pathway
N00215
KITLG-KIT-RAS-ERK signaling pathway
N00216
HGF-MET-RAS-ERK signaling pathway
N00217
FLT3LG-FLT3-RAS-ERK signaling pathway
N00229
TGFA-EGFR-RAS-ERK signaling pathway
N00230
TGFA-overexpression to RAS-ERK signaling pathway
N00233
IGF-IGF1R-RAS-ERK signaling pathway
N00235
IGF2-overexpression to RAS-ERK signaling pathway
N00237
IGF1R-overexpression to RAS-ERK signaling pathway
N00246
HGF-overexpression to RAS-ERK signaling pathway
N00248
MET-overexpression to RAS-ERK signaling pathway
N00252
Amplified ERBB2 to RAS-ERK signaling pathway
N00259
Amplified MET to RAS-ERK signaling pathway
N00276
EGF-overexpression to RAS-ERK signaling pathway
N00277
EREG-EGFR-RAS-ERK signaling pathway
N00278
EREG-overexpression to RAS-ERK signaling pathway
N00279
AREG-EGFR-RAS-ERK signaling pathway
N00280
AREG-overexpression to RAS-ERK signaling pathway
N00367
HPV E5 to EGFR-RAS-ERK signaling pathway
N00369
HPV E5 to PDGFR-RAS-ERK signaling pathway
N00386
HCMV gB to PDGFR-RAS-ERK signaling pathway
N00392
HCMV gB to EGFR-RAS-ERK signaling pathway
N00513
Mutation-activated EGFR to RAS-ERK signaling pathway
N00518
HCV Core to ERK signaling pathway
N00538
Ca2+-PYK2-RAS-ERK signaling pathway
N00539
HBV HBx to Ca2+-PYK2-RAS-ERK signaling pathway
N00540
HBV HBx to RAS-ERK signaling pathway
N00546
CXCL12-CXCR4-PKC-ERK signaling pathaway
N00547
HBV LHBs to PKC-ERK signaling pathway
N00744
IAV HA to ERK signaling pathway
N00876
Mutation-inactivated FGF8 to RAS-ERK signaling pathway
N00877
Mutation-inactivated FGF17 to RAS-ERK signaling pathway
N00878
Mutation-inactivated FGFR1 to RAS-ERK signaling pathway
N00913
Mutation-inactivated IGF1 to RAS-ERK signaling pathway
N00914
Mutation-inactivated IGF1R to RAS-ERK signaling pathway
N00994
AGE-RAGE signaling pathway
N00996
Mutation-caused aberrant Abeta to AGE-RAGE signaling pathway
N01062
Mutation-activated MET to RAS-ERK signaling pathway
N01064
Mutation-activated RET to RAS-ERK signaling pathway
N01119
RAC/CDC42-PAK-ERK signaling pathway
N01343
ACH-CHRN-RAS-ERK signaling pathway
N01344
NNK/NNN to RAS-ERK signaling pathway
N01351
E2-ER-RAS-ERK signaling pathway
N01352
BPA to RAS-ERK signaling pathway
N01353
E2 to RAS-ERK signaling pathway
N01354
BPA to RAS-ERK signaling pathway
N01360
P4-PR-RAS-ERK signaling pathway
N01361
P4/MPA to PR-RAS-ERK signaling pathway
N01408
Metals to RAS-ERK signaling pathway
N10007
Kinase inhibitor to BRAF mutation
N10008
Kinase inhibitor to MEK downstream of BRAF mutation
Disease
H00014
Non-small cell lung cancer
H00020
Colorectal cancer
H00032
Thyroid cancer
H00038
Melanoma
H00523
Noonan syndrome and related disorders
H01512
Langerhans cell histiocytosis
H01738
Noonan syndrome
H01745
Cardiofaciocutaneous syndrome
H01984
Leopard syndrome
H02425
Erdheim-Chester disease
Drug target
Dabrafenib (
DG00721
):
D10064
D10104
<JP/US>
Encorafenib:
D11053
<JP/US>
Lifirafenib (
DG03009
):
D11410
D11411
Regorafenib (
DG00720
):
D10137
<JP/US>
D10138
Sorafenib (
DG00713
):
D06272
<JP/US>
D08524
Tovorafenib:
D12291
Vemurafenib:
D09996
<JP/US>
Brite
KEGG Orthology (KO) [BR:
hsa00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
673 (BRAF)
04012 ErbB signaling pathway
673 (BRAF)
04015 Rap1 signaling pathway
673 (BRAF)
04068 FoxO signaling pathway
673 (BRAF)
04024 cAMP signaling pathway
673 (BRAF)
04150 mTOR signaling pathway
673 (BRAF)
09140 Cellular Processes
09144 Cellular community - eukaryotes
04510 Focal adhesion
673 (BRAF)
09142 Cell motility
04810 Regulation of actin cytoskeleton
673 (BRAF)
09150 Organismal Systems
09151 Immune system
04650 Natural killer cell mediated cytotoxicity
673 (BRAF)
04062 Chemokine signaling pathway
673 (BRAF)
09152 Endocrine system
04910 Insulin signaling pathway
673 (BRAF)
04914 Progesterone-mediated oocyte maturation
673 (BRAF)
04928 Parathyroid hormone synthesis, secretion and action
673 (BRAF)
09153 Circulatory system
04270 Vascular smooth muscle contraction
673 (BRAF)
09156 Nervous system
04726 Serotonergic synapse
673 (BRAF)
04720 Long-term potentiation
673 (BRAF)
04730 Long-term depression
673 (BRAF)
04722 Neurotrophin signaling pathway
673 (BRAF)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
673 (BRAF)
05205 Proteoglycans in cancer
673 (BRAF)
05208 Chemical carcinogenesis - reactive oxygen species
673 (BRAF)
09162 Cancer: specific types
05210 Colorectal cancer
673 (BRAF)
05212 Pancreatic cancer
673 (BRAF)
05225 Hepatocellular carcinoma
673 (BRAF)
05226 Gastric cancer
673 (BRAF)
05214 Glioma
673 (BRAF)
05216 Thyroid cancer
673 (BRAF)
05221 Acute myeloid leukemia
673 (BRAF)
05220 Chronic myeloid leukemia
673 (BRAF)
05218 Melanoma
673 (BRAF)
05211 Renal cell carcinoma
673 (BRAF)
05219 Bladder cancer
673 (BRAF)
05215 Prostate cancer
673 (BRAF)
05213 Endometrial cancer
673 (BRAF)
05224 Breast cancer
673 (BRAF)
05223 Non-small cell lung cancer
673 (BRAF)
09172 Infectious disease: viral
05161 Hepatitis B
673 (BRAF)
05160 Hepatitis C
673 (BRAF)
09164 Neurodegenerative disease
05010 Alzheimer disease
673 (BRAF)
05022 Pathways of neurodegeneration - multiple diseases
673 (BRAF)
09165 Substance dependence
05034 Alcoholism
673 (BRAF)
09167 Endocrine and metabolic disease
04934 Cushing syndrome
673 (BRAF)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
673 (BRAF)
01522 Endocrine resistance
673 (BRAF)
09180 Brite Hierarchies
09181 Protein families: metabolism
01001 Protein kinases [BR:
hsa01001
]
673 (BRAF)
Enzymes [BR:
hsa01000
]
2. Transferases
2.7 Transferring phosphorus-containing groups
2.7.11 Protein-serine/threonine kinases
2.7.11.1 non-specific serine/threonine protein kinase
673 (BRAF)
Protein kinases [BR:
hsa01001
]
Serine/threonine kinases: TKL group
RAF family [OT]
673 (BRAF)
BRITE hierarchy
SSDB
Ortholog
Paralog
Gene cluster
GFIT
Motif
Pfam:
PK_Tyr_Ser-Thr
Pkinase
RBD
C1_1
Kinase-like
zf-RING-like
ABC1
C1_2
Pkinase_fungal
APH
Kdo
Motif
Other DBs
NCBI-GeneID:
673
NCBI-ProteinID:
NP_004324
OMIM:
164757
HGNC:
1097
Ensembl:
ENSG00000157764
Pharos:
P15056
(Tclin)
UniProt:
P15056
Structure
PDB
LinkDB
All DBs
Position
7:complement(140713328..140924929)
Genome browser
AA seq
766 aa
AA seq
DB search
MAALSGGGGGGAEPGQALFNGDMEPEAGAGAGAAASSAADPAIPEEVWNIKQMIKLTQEH
IEALLDKFGGEHNPPSIYLEAYEEYTSKLDALQQREQQLLESLGNGTDFSVSSSASMDTV
TSSSSSSLSVLPSSLSVFQNPTDVARSNPKSPQKPIVRVFLPNKQRTVVPARCGVTVRDS
LKKALMMRGLIPECCAVYRIQDGEKKPIGWDTDISWLTGEELHVEVLENVPLTTHNFVRK
TFFTLAFCDFCRKLLFQGFRCQTCGYKFHQRCSTEVPLMCVNYDQLDLLFVSKFFEHHPI
PQEEASLAETALTSGSSPSAPASDSIGPQILTSPSPSKSIPIPQPFRPADEDHRNQFGQR
DRSSSAPNVHINTIEPVNIDDLIRDQGFRGDGGSTTGLSATPPASLPGSLTNVKALQKSP
GPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDV
AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHH
LHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATV
KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN
NRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS
LPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH
NT seq
2301 nt
NT seq
+upstream
nt +downstream
nt
atggcggcgctgagcggtggcggtggtggcggcgcggagccgggccaggctctgttcaac
ggggacatggagcccgaggccggcgccggcgccggcgccgcggcctcttcggctgcggac
cctgccattccggaggaggtgtggaatatcaaacaaatgattaagttgacacaggaacat
atagaggccctattggacaaatttggtggggagcataatccaccatcaatatatctggag
gcctatgaagaatacaccagcaagctagatgcactccaacaaagagaacaacagttattg
gaatctctggggaacggaactgatttttctgtttctagctctgcatcaatggataccgtt
acatcttcttcctcttctagcctttcagtgctaccttcatctctttcagtttttcaaaat
cccacagatgtggcacggagcaaccccaagtcaccacaaaaacctatcgttagagtcttc
ctgcccaacaaacagaggacagtggtacctgcaaggtgtggagttacagtccgagacagt
ctaaagaaagcactgatgatgagaggtctaatcccagagtgctgtgctgtttacagaatt
caggatggagagaagaaaccaattggttgggacactgatatttcctggcttactggagaa
gaattgcatgtggaagtgttggagaatgttccacttacaacacacaactttgtacgaaaa
acgtttttcaccttagcattttgtgacttttgtcgaaagctgcttttccagggtttccgc
tgtcaaacatgtggttataaatttcaccagcgttgtagtacagaagttccactgatgtgt
gttaattatgaccaacttgatttgctgtttgtctccaagttctttgaacaccacccaata
ccacaggaagaggcgtccttagcagagactgccctaacatctggatcatccccttccgca
cccgcctcggactctattgggccccaaattctcaccagtccgtctccttcaaaatccatt
ccaattccacagcccttccgaccagcagatgaagatcatcgaaatcaatttgggcaacga
gaccgatcctcatcagctcccaatgtgcatataaacacaatagaacctgtcaatattgat
gacttgattagagaccaaggatttcgtggtgatggaggatcaaccacaggtttgtctgct
accccccctgcctcattacctggctcactaactaacgtgaaagccttacagaaatctcca
ggacctcagcgagaaaggaagtcatcttcatcctcagaagacaggaatcgaatgaaaaca
cttggtagacgggactcgagtgatgattgggagattcctgatgggcagattacagtggga
caaagaattggatctggatcatttggaacagtctacaagggaaagtggcatggtgatgtg
gcagtgaaaatgttgaatgtgacagcacctacacctcagcagttacaagccttcaaaaat
gaagtaggagtactcaggaaaacacgacatgtgaatatcctactcttcatgggctattcc
acaaagccacaactggctattgttacccagtggtgtgagggctccagcttgtatcaccat
ctccatatcattgagaccaaatttgagatgatcaaacttatagatattgcacgacagact
gcacagggcatggattacttacacgccaagtcaatcatccacagagacctcaagagtaat
aatatatttcttcatgaagacctcacagtaaaaataggtgattttggtctagctacagtg
aaatctcgatggagtgggtcccatcagtttgaacagttgtctggatccattttgtggatg
gcaccagaagtcatcagaatgcaagataaaaatccatacagctttcagtcagatgtatat
gcatttggaattgttctgtatgaattgatgactggacagttaccttattcaaacatcaac
aacagggaccagataatttttatggtgggacgaggatacctgtctccagatctcagtaag
gtacggagtaactgtccaaaagccatgaagagattaatggcagagtgcctcaaaaagaaa
agagatgagagaccactctttccccaaattctcgcctctattgagctgctggcccgctca
ttgccaaaaattcaccgcagtgcatcagaaccctccttgaatcgggctggtttccaaaca
gaggattttagtctatatgcttgtgcttctccaaaaacacccatccaggcagggggatat
ggtgcgtttcctgtccactga
DBGET
integrated database retrieval system